A Short Regimen for Rifampicin-resistant Isoniazid-susceptible TB
Clinical trial NCT06526039 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06526039
- Sponsor
- Taipei Medical University WanFang Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2028-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.